Results 271 to 280 of about 296,701 (305)

Intravascular Brachytherapy for the Management of Repeated Multimetal-Layered Drug-Eluting Coronary Stent Restenosis

Circulation. Cardiovascular Interventions, 2018
Background: Because of the widespread acceptance of percutaneous coronary intervention with drug-eluting stents as an effective treatment strategy for in-stent restenosis, it is common to encounter multimetal layer stent restenosis in the recent years ...
M. Varghese, Samit Bhatheja, U. Baber, Safwan Kezbor, Aditi Chincholi, Surbhi Chamaria, M. Buckstein, R. Bakst, A. Kini, Samin K. Sharma   +9 more
semanticscholar   +1 more source

Phantom Study of In-Stent Restenosis at High-Spatial-Resolution CT.

Radiology, 2018
Purpose To examine the diagnostic performance of high-spatial-resolution (HSR) CT with 0.25-mm section thickness for evaluating renal artery in-stent restenosis.
H. Onishi, M. Hori, T. Ota, A. Nakamoto, K. Osuga, M. Tatsumi, H. Fukui, S. Tsukagoshi, Ayumi Uranishi, Y. Saito, Akira Taniguchi, Y. Enchi, Kazuhiko Sato, N. Tomiyama   +13 more
semanticscholar   +1 more source

In-stent Restenosis of drug-eluting Stents

Future Cardiology, 2013
Drug-eluting stents (DES) have emerged as an improved alternative to bare-metal stents by demonstrating reduced rates of restenosis and target lesion revascularization. This emergence has led to the unrestricted use of DES for various indications and lesions, and subsequently revealed DES in-stent restenosis as a novel interventional therapeutic ...
Sa'ar, Minha, Augusto D, Pichard, Ron, Waksman   +2 more
openaire   +2 more sources

In-stent restenosis.

Italian heart journal : official journal of the Italian Federation of Cardiology, 2001
Even after optimal immediate results, restenosis still occurs in a relevant percentage of patients after stent implantation. This disappointing outcome has strong clinical and socio-economical implications and has become a major target of research in cardiology.
openaire   +4 more sources

In-stent restenosis in vertebral artery stenting

Neuroradiology, 2007
Sir, Tsutsumi et al. reported the clinical and angiographic data on 12 patients receiving stent deployment for symptomatic ostial vertebral artery (VA) stenosis [1]. The in-stent re-stenosis (ISR) rate was surprising low – 0% angiographic restenosis at 12 months and 8% after a mean of 31.5 months clinical/radiological follow-up.
Yen-Hung, Lin, Hsien-Li, Kao
openaire   +2 more sources

Treatment of in-stent restenosis

International Journal of Cardiology, 2005
Since its introduction in 1977, percutaneous coronary intervention (PCI) has revolutionized the treatment of coronary artery disease by providing a safe and feasible alternative to coronary bypass graft (CABG) surgery [1]. The subsequent development of coronary stents has had a further positive impact on the clinical effectiveness and predictability of
Thuraia, Nageh, Bernhard, Meier
openaire   +2 more sources

Pathology of in-stent restenosis

Current Opinion in Lipidology, 1999
The process of in-stent restenosis parallels wound healing responses. Stent deployment results in early thrombus deposition and acute inflammation, granulation tissue development, and ultimately smooth muscle cell proliferation and extracellular matrix synthesis.
R, Virmani, A, Farb
openaire   +2 more sources

Restenosis after carotid artery stenting

Vascular, 2017
As a common etiology for ischemic stroke, atherosclerotic carotid stenosis has been targeted by vascular surgery since 1950s. Compared with carotid endarterectomy, carotid angioplasty and stenting (CAS) is almost similarly efficacious and less invasive. These advantages make CAS an alternative in treating carotid stenosis.
Zhengze, Dai, Gelin, Xu
openaire   +2 more sources

Mechanisms of drug-eluting stent restenosis

Cardiovascular Intervention and Therapeutics, 2020
J. Aoki, K. Tanabe
semanticscholar   +1 more source

IN-STENT RESTENOSIS

2015
Koroner girisimlerde stentlerin kullanılması koroner arter hastalıgının tedavisini dramatik olarak degistirmistir. Ancak bu girisim sıklıkla restenoz adı verilen bir süreçle sınırlanmaktadır. Restenozun özellikle fokal restenozların ilk tedavi seçenegi tekrarlayan balon anjiyoplastilerdir.
KARAKAYA, Osman, ESEN, Ali Metin
openaire   +1 more source